I.4 Effects of anti-oestrogens on insulin-like growth factor (IGF-I) physiology systemically and in the uterus

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Pollak, M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; FULVESTRANT; MITOGENIC AGENT; SOMATOMEDIN C; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CONFERENCE PAPER; ESTROGEN BLOOD LEVEL; GENE EXPRESSION; HORMONAL REGULATION; HYPERTROPHY; HYPOPHYSECTOMY; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; UTERUS; UTERUS CANCER;

EID: 0031683551     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00087-2     Document Type: Conference Paper

References (12)

1. Pollak M, Costantino J, Polychronakos C, et al. Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst 1990, 82, 1693-1697.
2. Friedl A, Jordan VC, Pollak M. Suppression of serum IGF-I levels in breast cancer patients during adjuvant tamoxifen therapy. Eur J Cancer 1993, 29A, 1368-1372.
3. Malaab SA, Pollak M, Goodyer CG. Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro. Eur J Cancer 1992, 28A, 788-793.
4. Tannenbaum GS, Gurd W, Lapointe M, Pollak M. Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin. Endocrinol 1992, 130, 395-3401.
5. Huynh HT, Tetenes E, Wallace L, Pollak M. In vivo inhibition of insulin-like growth factor-I gene expression by tamoxifen. Cancer Res 1993, 53, 1727-1730.
6. Weckbecker G, Tolcsvai L, Stolz B, Pollak M, Bruns C. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res 1994, 54, 6334-6337.
7. Huynh HT, Pollak M. Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue. Biochem Biophys Res Comm 1994, 203, 253-259.
8. Huynh HT, Nickerson T, Pollak M, Yang XF. Regulation of insulin-like growth factor I receptor gene expression by the pure antiestrogen ICI 182, 780. Clin Cancer Res 1996, 2, 2037-2042.
9. Huynh HT, Yang XF, Pollak M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 1996, 271, 1016-1021.
10. Huynh HT, Yang XF, Pollak M. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth and Differ 1996, 7, 1501-1506.
11. Huynh HT, Yang XF, Pollak M. IGF-1 gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res 1993, 53, 5585-5588.
12. Huynh HT, Pollak M. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine IGF binding protein 3 gene expression. Cancer Res 1994, 54, 3115-3119.